all beaten down
I would say buy all three.
I'd say PSDV. FDA decision tomorrow. Also keeping an eye on ACHN.
E povero Foggia. Dov'e` arrivato.
AMRN among those 3 imo
Hi Bio my count of 10 already included Smith. Please give a look to the Draft meeting Roster
None of the above. Smalltime bios are toast in today's market!
In comparison to AMRN, DNDN is a picnic at the beach with a bunch of topless beauties